New hope for eczema sufferers with painful itchy nodules
NCT ID NCT05451316
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study looked at how well the drug upadacitinib works for people in Japan with moderate to severe eczema that also causes hard, itchy bumps called prurigo nodularis. About 200 adults and teens took the drug once daily for 48 weeks. The main goal was to see if their worst itch improved by at least 4 points on a 10-point scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tohoku Medical and Pharmaceuti /ID# 252486
Sendai, Miyagi, 983-0005, Japan
Conditions
Explore the condition pages connected to this study.